Evidence map›Paper›PMID 39357336›Full record

ArticleBiochemical and biophysical research communications2024

Transgenic expression of human cytochrome P450 2E1 in C. elegans and rat PC-12 cells sensitizes to ethanol-induced locomotor and mitochondrial effects.

Hyland C Gonzalez, Kelly R Misare, Tsultrim T Mendenhall, Bethany J Wolf, Patrick J Mulholland, Kacy L Gordon, Jessica H Hartman

Abstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. A Robust Chemical-free Platform for Age-SynchronizedbioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hyland C GonzalezDept of Biochemistry and Molecular Biology, Medical University of South Carolina, 173 Ashley Ave. BSB 501 | MSC 509, Charleston, SC, 29425, USA.
Kelly R MisareDept of Biochemistry and Molecular Biology, Medical University of South Carolina, 173 Ashley Ave. BSB 501 | MSC 509, Charleston, SC, 29425, USA.
Tsultrim T MendenhallDept of Biochemistry and Molecular Biology, Medical University of South Carolina, 173 Ashley Ave. BSB 501 | MSC 509, Charleston, SC, 29425, USA.
Bethany J WolfDept of Public Health Sciences, Medical University of South Carolina, 135 Cannon St., Charleston, SC, 29425, USA.
Patrick J MulhollandDept of Neuroscience, Charleston Alcohol Research Center, Medical University of South Carolina, 30 Courtenay Drive, Charleston, SC, 29425, USA.
Kacy L GordonDept of Biology, The University of North Carolina at Chapel Hill, 316 Fordham Hall, Chapel Hill, NC, 27599, USA; UNC Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, 450 West Dr, Chapel Hill, NC, 27599, USA.
Jessica H HartmanDept of Biochemistry and Molecular Biology, Medical University of South Carolina, 173 Ashley Ave. BSB 501 | MSC 509, Charleston, SC, 29425, USA; Dept of Regenerative Medicine and Cell Biology, Medical University of South Carolina, 173 Ashley Ave. BSB 501 | MSC 509, Charleston, SC, 29425, USA. Electronic address: hartmanj@musc.edu.

Funding

TREATING ETHANOL WITHDRAWAL WITH LORAZEPAM/NALTREXONEP50AA010761 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Patrick J. Mulholland · 1996 to 2026
$46.8M
MUSC Minority Student Development ProgramR25GM072643 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ERGUL, ADVIYE, RINKER, JENNIFER ANNE · 2005 to 2023
$5.8M
MUSC Post-Baccalaureate Research Education ProgramR25GM113278 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI DELEON-PENNELL, KRISTINE Y, PENROD-MARTIN, RACHEL · 2015 to 2024
$2.7M
Extreme cell growth in support of stem cell proliferation and niche exitR35GM147704 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Kacy Lynn Gordon · 2022 to 2026
$2.1M
Subcellular-targeted CYP2E1 and alcohol in the brainR01AA029664 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Jessica Helene Hartman · 2023 to 2026
$1.4M
Exercise, MANF, and Chemical-Induced NeurodegenerationR00ES029552 · NIEHS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI HARTMAN, JESSICA HELENE · 2021 to 2023
$751k
MUSC IMSDT32GM152386 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ERGUL, ADVIYE, RINKER, JENNIFER ANNE · 2024 to 2024
$460k
Superresolution Confocal Microscope for Biomedical ImagingS10OD021532 · OD · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MULHOLLAND, PATRICK J. · 2017 to 2017
$437k
Role of Mitochondrial CYP2E1 in Chemical Exposure-Driven NeurodegenerationF32ES027306 · NIEHS · DUKE UNIVERSITY · PI HARTMAN, JESSICA HELENE · 2016 to 2018
$171k
NIAAA NIH HHS P50 AA010761NIAAA NIH HHS R01 AA029664NIEHS NIH HHS F32 ES027306NIEHS NIH HHS R00 ES029552NIGMS NIH HHS R25 GM072643NIGMS NIH HHS R25 GM113278NIGMS NIH HHS R35 GM147704NIGMS NIH HHS T32 GM152386NIH HHS S10 OD021532
6 · The paper itself

Abstract

Chronic alcohol (ethanol) use is increasing in the United States and has been linked to numerous health issues in multiple organ systems including neurological dysfunction and diseases. Ethanol toxicity is mainly driven by the metabolite acetaldehyde, which is generated through three pathways: alcohol dehydrogenase (ADH2), catalase (CAT), and cytochrome P450 2E1 (CYP2E1). ADH2, while the main ethanol clearance pathway in the liver, is not expressed in the mammalian brain, resulting in CAT and CYP2E1 driving local metabolism of ethanol in the central nervous system. CYP2E1 is known to generate reactive metabolites and reactive oxygen species and localizes to the mitochondria (mtCYP2E1) and endoplasmic reticulum (erCYP2E1). We sought to understand the consequences of mtCYP2E1 and erCYP2E1 in the nervous system during acute ethanol exposure. To answer this question, we generated transgenic Caenorhabditis elegans roundworms expressing human CYP2E1 in the mitochondria, endoplasmic reticulum, or both and exposed them to ethanol. We found that at lower concentrations, wild-type and mtCYP2E1-expressing worms had a small but significant inhibition of locomotion, whereas the erCYP2E1-expressing worms showed protection from this inhibition. At higher doses, all strains had reduced locomotion, but the erCYP2E1-expressing worms recovered faster than wild-type controls. CYP2E1 expression, regardless of organellar targeting, reduced mitochondrial respiration in response to ethanol. Similarly, transgenic expression of CYP2E1 in either organelle in PC-12 rat neuronal cell lines sensitized them to ethanol-induced cell death. Together, these findings suggest that subcellular localization of CYP2E1 impacts behavioral effects of ethanol and should be further studied in the mammalian central nervous system.

Indexed as

Animals, Genetically ModifiedCaenorhabditis elegansCytochrome P-450 CYP2E1EthanolLocomotionMitochondriaAnimalsEndoplasmic ReticulumHumansPC12 CellsRatsCytochrome P-450 CYP2E1EthanolCaenorhabditis elegansCYP2E1Endoplasmic reticulumEthanolMetabolismMitochondria

Identifiers

PMID39357336
PMCPMC11540131

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.